Die Thorakoskopische Talkumpleurodese Mit Pleurabiopsie – Eine Retrospektive Analyse Bei Patienten Mit Malignem Pleuraerguss

B. Hoksch,N. Seidel,M. Beshay,R. A. Schmid
DOI: https://doi.org/10.1055/s-0029-1224646
2009-01-01
Zentralblatt für Chirurgie
Abstract:Background: The thoracoscopic pleurodesis with talc is an established therapy in case of malignant pleural effusion. With the instillation of talc a localised inflammation is induced. However, sometimes it turns into a severe systemic reaction. In this study of the postoperative course, the question is examined whether a pleural biopsy is an additional risk factor for morbidity and mortality after talc pleurodesis.Patients and Methods: Between January 2002 and December 2004, 77 patients with a malignant pleural effusion were enrolled in this retrospective trial. All patients received a thoracoscopic talc pleurodesis. The patients were divided retrospectively into two groups: 50 patients with an intraoperative pleural biopsy, 27 patients without a biopsy were the control group. C-reactive protein (CrP), leukocytes, and creatinine were analysed.Results: In both groups, CrP and leukocytes increased postoperatively with a peak on day 2 or 3. In general, the analysed data for creatinine showed in the median standard values but with a high range up to at most 317 mu mol/L on the 2(nd) postoperative day, also in both groups. At no time was any significant difference in laboratory values seen among the two groups. Concerning morbidity and mortality also no significant difference could be determined.Conclusions: There were no significant differences for the examined laboratory values or for the morbidity/mortality between the two groups. That is why a disadvantage for patients with an intraoperative pleural biopsy is not to be expected.
What problem does this paper attempt to address?